quinoxalines has been researched along with (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bannon, AW; Deng, H; Gavva, NR; Gore, A; Han, B; Hovland, DN; Juan, T; Klionsky, L; Kuang, R; Le, A; Lehto, SG; Louis, JC; Magal, E; Norman, MH; Surapaneni, S; Tamir, R; Treanor, JJ; Wang, J; Youngblood, B; Zhu, D | 1 |
1 other study(ies) available for quinoxalines and (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide
| Article | Year |
|---|---|
The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation.
Topics: Acrylamides; Animals; Benzothiazoles; Blood-Brain Barrier; Body Temperature Regulation; Bridged Bicyclo Compounds, Heterocyclic; Capsaicin; Cells, Cultured; CHO Cells; Conserved Sequence; Cricetinae; Cricetulus; Dogs; Female; Fever; Humans; Hypothermia; Macaca fascicularis; Male; Quinoxalines; Rats; Rats, Sprague-Dawley; Species Specificity; Sulfonamides; Thiourea; TRPV Cation Channels | 2007 |